Lee JY - Search Results

1

Tumor-intrinsic role of ICAM-1 in driving metastatic progression of triple-negative breast cancer through direct interaction with EGFR.

Kang JH, Uddin N, Kim S, Zhao Y, Yoo KC, Kim MJ, Hong SA, Bae S, Lee JY, Shin I, Jin YW, O'Hagan HM, Yi JM, Lee SJ. Kang JH, et al. Among authors: lee sj, lee jy. Mol Cancer. 2024 Oct 16;23(1):230. doi: 10.1186/s12943-024-02150-4. Mol Cancer. 2024. PMID: 39415210 Free PMC article.

2

Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts.

Chung H, Jung YM, Shin DH, Lee JY, Oh MY, Kim HJ, Jang KS, Jeon SJ, Son KH, Kong G. Chung H, et al. Among authors: lee jy. Int J Cancer. 2008 Feb 15;122(4):816-22. doi: 10.1002/ijc.23182. Int J Cancer. 2008. PMID: 17957784

3

The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer.

Oh M, Lee JY, Shin DH, Park JH, Oian T, Kim HJ, Cho SD, Oh SH, Min YK, Kong G. Oh M, et al. Among authors: lee jy. Cancer Sci. 2011 Mar;102(3):597-604. doi: 10.1111/j.1349-7006.2010.01817.x. Epub 2011 Jan 10. Cancer Sci. 2011. PMID: 21205071 Free PMC article.

4

NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.

Jeong GY, Park MK, Choi HJ, An HW, Park YU, Choi HJ, Park J, Kim HY, Son T, Lee H, Min KW, Oh YH, Lee JY, Kong G. Jeong GY, et al. Among authors: lee h, lee jy. Cancer Res. 2021 Jan 1;81(1):77-90. doi: 10.1158/0008-5472.CAN-20-0360. Epub 2020 Sep 23. Cancer Res. 2021. PMID: 32967925

5

Role of MEL-18 Amplification in Anti-HER2 Therapy of Breast Cancer.

Lee JY, Joo HS, Choi HJ, Jin S, Kim HY, Jeong GY, An HW, Park MK, Lee SE, Kim WS, Son T, Min KW, Oh YH, Kong G. Lee JY, et al. Among authors: lee se. J Natl Cancer Inst. 2019 Jun 1;111(6):609-619. doi: 10.1093/jnci/djy151. J Natl Cancer Inst. 2019. PMID: 30265336

6

Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.

Lee JY, Kong G. Lee JY, et al. Cell Mol Life Sci. 2016 Dec;73(24):4643-4660. doi: 10.1007/s00018-016-2313-z. Epub 2016 Jul 26. Cell Mol Life Sci. 2016. PMID: 27460000 Free PMC article. Review.

7

Mel-18 negatively regulates INK4a/ARF-independent cell cycle progression via Akt inactivation in breast cancer.

Lee JY, Jang KS, Shin DH, Oh MY, Kim HJ, Kim Y, Kong G. Lee JY, et al. Cancer Res. 2008 Jun 1;68(11):4201-9. doi: 10.1158/0008-5472.CAN-07-2570. Cancer Res. 2008. PMID: 18519679 Free article.

8

Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.

Choi HJ, Joo HS, Won HY, Min KW, Kim HY, Son T, Oh YH, Lee JY, Kong G. Choi HJ, et al. Among authors: lee jy. J Natl Cancer Inst. 2018 Apr 1;110(4). doi: 10.1093/jnci/djx207. J Natl Cancer Inst. 2018. PMID: 29028222

9

Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha.

Kim HJ, Chung H, Yoo YG, Kim H, Lee JY, Lee MO, Kong G. Kim HJ, et al. Among authors: lee jy, lee mo. Mol Cancer Res. 2007 Apr;5(4):321-9. doi: 10.1158/1541-7786.MCR-06-0218. Mol Cancer Res. 2007. PMID: 17426247 Free article.

10

Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.

Kim H, Chung H, Kim HJ, Lee JY, Oh MY, Kim Y, Kong G. Kim H, et al. Among authors: lee jy. Breast Cancer Res Treat. 2008 Nov;112(2):287-96. doi: 10.1007/s10549-007-9871-6. Epub 2007 Dec 25. Breast Cancer Res Treat. 2008. PMID: 18158619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,857 results

Search Page

Filters